Relief Therapeutics Holding (Relief Therapeutics Holding) Net Margin % : -1,384.60% (As of Dec. 2023)

View and export this data going back to 1990. Start your Free Trial

What is Relief Therapeutics Holding Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Relief Therapeutics Holding's Net Income for the six months ended in Dec. 2023 was $-48.20 Mil. Relief Therapeutics Holding's Revenue for the six months ended in Dec. 2023 was $3.48 Mil. Therefore, Relief Therapeutics Holding's net margin for the quarter that ended in Dec. 2023 was -1,384.60%.

The historical rank and industry rank for Relief Therapeutics Holding's Net Margin % or its related term are showing as below:

RLFTF' s Net Margin % Range Over the Past 10 Years
Min: -112226.67 Med: -1045.02 Max: -77.17
Current: -1627.4

RLFTF's Net Margin % is ranked worse than
78.49% of 1032 companies
in the Biotechnology industry
Industry Median: -156.25 vs RLFTF: -1627.40

Relief Therapeutics Holding Net Margin % Historical Data

The historical data trend for Relief Therapeutics Holding's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Net Margin % Chart

Relief Therapeutics Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-1,044.98

-835.28

-1,627.44

Relief Therapeutics Holding Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial															-603.02	-817.30	-855.69	-1,869.20	-1,384.60

Competitive Comparison of Relief Therapeutics Holding's Net Margin %

For the Biotechnology subindustry, Relief Therapeutics Holding's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relief Therapeutics Holding's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Net Margin % distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Net Margin % falls into.

Relief Therapeutics Holding Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Relief Therapeutics Holding's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-113.53	/	6.976
	=	-1,627.44 %

Relief Therapeutics Holding's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-48.198	/	3.481
	=	-1,384.60 %

Relief Therapeutics Holding (OTCPK:RLFTF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Relief Therapeutics Holding Net Margin % Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (Relief Therapeutics Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFz:UK RLF:Switzerland

Address

Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.